AccuLine Overview
AccuLine was founded with the vision to save the lives of millions of people worldwide by preventing the next heart attack. AccuLine is developing CORA – an accurate, non-invasive, swift, and cost-effective examination for early detection of CAD, designed to replace the inaccurate, time-consuming, and labor-intensive stress test examinations. Through a brief 4-minute evaluation of three vital signs - the heart's electrical activity, oxygen saturation levels, and respiratory phase, CORA automatically generates results, ensuring a seamless and efficient process. CORA has the potential to save the lives of millions of patients worldwide, while simultaneously decreasing health care-related costs. AccuLine has received grants from Google and the Israeli Innovation Authority, and among its shareholders are Mayo Clinic, eHealth Ventures and Maccabi Healthcare Services.
Cumulative Funding Raised Over Time ($)
$3.5M
$3.8MFeb 2022
Latest News
growth-positive
Israeli startup raises $4.2 million Seed round to detect heart attacks early | CTech
Israeli healthtech startup AccuLine has raised $4.2 million in a seed funding round. The round was led by eHealth Ventures and Maccabi Healthcare Services and included a grant from the Israel Innovation Authority and Googles AI Startups Fund. The Mayo Clinic also invested and signed a know-how agreement with AccuLine for the development of the CORA system for the U.S. market. The CORA system allows for early detection of coronary artery disease. The funding will be used for the continued development and commercialization of the CORA system.
InvestmentPartnersCustomers
The Israeli development will prevent a heart attack long before it happens
growth-positive
AccuLine Announces Know-How License Agreement with Mayo Clinic to Advance Early Detection of Heart Attacks
Digital health startup AccuLine has announced a collaboration with Mayo Clinic to advance CORA, a solution designed for the early detection of coronary artery disease (CAD). Mayo Clinic will also become a shareholder in AccuLine. The CORA system uses AI-driven signal processing algorithms to measure and interpret multiple biological indicators, facilitating the evaluation of an individuals coronary arteries. The collaboration will focus on adapting CORA for the U.S. market, aligning with FDA approval requirements, and integrating the technology as a preferred diagnostic tool for early CAD detection.
PartnersInvestment
growth-positive
Assuta's 'RISE with US' launches with six startups looking for international markets | CTech
Assuta’s innovation arm RISE has launched a program in collaboration with Philadelphia-based University City Science Center to help startups penetrate overseas markets. The program, RISE with US, selected six companies from 101 applicants, focusing on digital, computational, AI, and big data healthcare solutions. The program operates in partnership with tech companies such as AWS, NVIDIA, LionBird venture capital fund, and law firms Reinhold Cohn & Co. and Naomi Asia & Co. The startups will have access to Assuta Medical Centers and clinical mentorship from doctors in their field.
PartnersCustomers
growth-positive
AccuLine is one of the finalists in the Reboot Forum “Leading Health Initiative of the Year” competition.
The article discusses the top 10 healthcare initiatives in Israel that aim to improve the countrys healthcare system. These initiatives include support for families caring for dementia patients, early detection of heart attacks, and monitoring of medical indicators through video. The initiatives are part of a competition by Yedioth Ahronoth and the Reboot Forum, which has been held since 2014. The winning initiative will receive a cash grant, professional exposure, and media coverage.
CustomersPartnersExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $6.25M |
| Last funding | $600K |
| Stage | Pre-Seed |
| Rounds | 5 |
| Investors | 4 |
Team Members
5
Employees: 11-50
Web & Social Links
| Website | acculine-medical.com |
Locations
Park Ofer, הפסגות 9, פתח תקווה, Israel
Photos & Videos
1 item(s)
AccuLine Business
Business models
B2B
Product stage
Clinical Trial
Employees
11-50
Sector
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
Artificial IntelligenceMachine LearningData StorageCloudTags (14)
medical-devicespreventionmachine-learningearly-detectionheart-failurealgorithmsartificial-intelligencenon-invasivedigital-healthcarediagnosticscardiovascularhealthcaresignal-processingcardiologyGeographic Markets
North AmericaAccuLine Financials
$6.25M
Total funding
Undisclosed
Capital raised
$600K
Last funding
Pre-Seed
Funding stage
5
Total rounds
4
Investors
Cumulative Funding Raised Over Time ($)
$3.5M
$3.8MFeb 2022
Private Equity Funding
Pre-Seed
Feb 2022
$375K
eHealth Ventures, Maccabi Healthcare Services, Undisclosed Investor(s)
Seed
$3.45M
eHealth Ventures, Maccabi Healthcare Services, Undisclosed Investor(s), Mayo Clinic Platform
Non-Equity Funding
GrantEvent
May 2024
$150K
Google
GrantEvent
May 2024
$600K
Israel Innovation Authority (Lead)
GrantEvent
$930K
Israel Innovation Authority (Lead)
AccuLine Lifecycle
Cumulative Funding Raised Over Time
$3.5M
$3.8MFeb 2022
All Events
Pre-Seed
Feb 2022
$375K
eHealth Ventures, Maccabi Healthcare Services, Undisclosed Investor(s)
Seed
$3.45M
eHealth Ventures, Maccabi Healthcare Services, Undisclosed Investor(s), Mayo Clinic Platform
GrantEvent
May 2024
$150K
Google
GrantEvent
May 2024
$600K
Israel Innovation Authority (Lead)
GrantEvent
$930K
Israel Innovation Authority (Lead)
AccuLine News
5 articles
growth-positive
Israeli startup raises $4.2 million Seed round to detect heart attacks early | CTech
Israeli healthtech startup AccuLine has raised $4.2 million in a seed funding round. The round was led by eHealth Ventures and Maccabi Healthcare Services and included a grant from the Israel Innovation Authority and Googles AI Startups Fund. The Mayo Clinic also invested and signed a know-how agreement with AccuLine for the development of the CORA system for the U.S. market. The CORA system allows for early detection of coronary artery disease. The funding will be used for the continued development and commercialization of the CORA system.
InvestmentPartnersCustomers
The Israeli development will prevent a heart attack long before it happens
growth-positive
AccuLine Announces Know-How License Agreement with Mayo Clinic to Advance Early Detection of Heart Attacks
Digital health startup AccuLine has announced a collaboration with Mayo Clinic to advance CORA, a solution designed for the early detection of coronary artery disease (CAD). Mayo Clinic will also become a shareholder in AccuLine. The CORA system uses AI-driven signal processing algorithms to measure and interpret multiple biological indicators, facilitating the evaluation of an individuals coronary arteries. The collaboration will focus on adapting CORA for the U.S. market, aligning with FDA approval requirements, and integrating the technology as a preferred diagnostic tool for early CAD detection.
PartnersInvestment
growth-positive
Assuta's 'RISE with US' launches with six startups looking for international markets | CTech
Assuta’s innovation arm RISE has launched a program in collaboration with Philadelphia-based University City Science Center to help startups penetrate overseas markets. The program, RISE with US, selected six companies from 101 applicants, focusing on digital, computational, AI, and big data healthcare solutions. The program operates in partnership with tech companies such as AWS, NVIDIA, LionBird venture capital fund, and law firms Reinhold Cohn & Co. and Naomi Asia & Co. The startups will have access to Assuta Medical Centers and clinical mentorship from doctors in their field.
PartnersCustomers
growth-positive
AccuLine is one of the finalists in the Reboot Forum “Leading Health Initiative of the Year” competition.
The article discusses the top 10 healthcare initiatives in Israel that aim to improve the countrys healthcare system. These initiatives include support for families caring for dementia patients, early detection of heart attacks, and monitoring of medical indicators through video. The initiatives are part of a competition by Yedioth Ahronoth and the Reboot Forum, which has been held since 2014. The winning initiative will receive a cash grant, professional exposure, and media coverage.
CustomersPartnersExpand
AccuLine Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 12 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
AccuLine Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | markets, not claimed |
| BI Verification | Yotam Maman |
| Registrar ID | 516557170 |
| Phone | +97238701637 |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2024-07-14T00:00:00.000Z |
| Created | 2022-06-07T00:00:00.000Z |
| Claimed | Yes |